Search Results

There are 7240 results for: content related to: Bortezomib induces apoptosis of endometrial cancer cells through micro RNA -17-5p by targeting p21

  1. You have free access to this content
    miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells

    FEBS Letters

    Volume 588, Issue 12, June 05, 2014, Pages: 2055–2062, Qiong Wu, Guanhong Luo, Zhiping Yang, Fei Zhu, Yanxin An, Yongquan Shi and Daiming Fan

    Version of Record online : 5 MAY 2014, DOI: 10.1016/j.febslet.2014.04.036

  2. You have free access to this content
    Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma

    International Journal of Cancer

    Volume 136, Issue 8, 15 April 2015, Pages: 1835–1844, Mu Hao, Meirong Zang, Erik Wendlandt, Yan Xu, Gang An, Dasen Gong, Fei Li, Fang Qi, Yanru Zhang, Ye Yang, Fenghuang Zhan and Lugui Qiu

    Version of Record online : 19 SEP 2014, DOI: 10.1002/ijc.29199

  3. You have free access to this content
    miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway

    Hepatology

    Volume 51, Issue 5, May 2010, Pages: 1614–1623, Fu Yang, Yixuan Yin, Fang Wang, Yuqi Wang, Ling Zhang, Ying Tang and Shuhan Sun

    Version of Record online : 1 FEB 2010, DOI: 10.1002/hep.23566

  4. Bortezomib for the treatment of multiple myeloma

    Intervention Review

    The Cochrane Library

    Kathleen Scott, Patrick J Hayden, Andrea Will, Keith Wheatley and Imelda Coyne

    Published Online : 20 APR 2016, DOI: 10.1002/14651858.CD010816.pub2

  5. You have free access to this content
    miR-17 regulates the proliferation and differentiation of the neural precursor cells during mouse corticogenesis

    The FEBS Journal

    Volume 281, Issue 4, February 2014, Pages: 1144–1158, Susu Mao, Hanqin Li, Qi Sun, Ke Zen, Chen-Yu Zhang and Liang Li

    Version of Record online : 15 JAN 2014, DOI: 10.1111/febs.12680

  6. Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review

    Drug Development Research

    Volume 76, Issue 6, September 2015, Pages: 296–317, Saira R. Ali, Karen J. Humphreys, Ross A. McKinnon and Michael Z. Michael

    Version of Record online : 25 AUG 2015, DOI: 10.1002/ddr.21268

  7. You have free access to this content
    MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells

    IUBMB Life

    Volume 64, Issue 8, August 2012, Pages: 697–704, Qian Wei, Yi-Xuan Li, Min Liu, Xin Li and Hua Tang

    Version of Record online : 22 JUN 2012, DOI: 10.1002/iub.1051

  8. You have free access to this content
    Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study

    American Journal of Hematology

    Volume 90, Issue 4, April 2015, Pages: 314–319, María Victoria Mateos, Paul G. Richardson, Meletios A. Dimopoulos, Antonio Palumbo, Kenneth C. Anderson, Hongliang Shi, Jennifer Elliott, Edward Dow, Helgi van de Velde, Liviu Niculescu and Jesús F. San Miguel

    Version of Record online : 27 FEB 2015, DOI: 10.1002/ajh.23933

  9. Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer

    The FEBS Journal

    Lin Liu, Jian Yang, Xuchao Zhu, Dan Li, Zhongwei Lv and Xiaoping Zhang

    Version of Record online : 12 MAY 2016, DOI: 10.1111/febs.13741

  10. Effects of the proteasome inhibitor, bortezomib, on cytodifferentiation and mineralization of periodontal ligament cells

    Journal of Periodontal Research

    Volume 50, Issue 2, April 2015, Pages: 248–255, J. Kitagaki, S. Miyauchi, C. J Xie, M. Yamashita, S. Yamada, M. Kitamura and S. Murakami

    Version of Record online : 20 JUN 2014, DOI: 10.1111/jre.12202

  11. You have free access to this content
    Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically

    BJU International

    Volume 109, Issue 8, April 2012, Pages: 1258–1268, Akinori Sato, Takako Asano, Keiichi Ito, Makoto Sumitomo and Tomohiko Asano

    Version of Record online : 2 SEP 2011, DOI: 10.1111/j.1464-410X.2011.10533.x

  12. SIOP 2015 Scientific Programme + Index

    Pediatric Blood & Cancer

    Volume 62, Issue S4, November 2015, Pages: S143–S418,

    Version of Record online : 9 SEP 2015, DOI: 10.1002/pbc.25715

  13. You have free access to this content
    Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis

    The EMBO Journal

    Volume 28, Issue 18, September 16, 2009, Pages: 2719–2732, Hong-li Yan, Geng Xue, Qian Mei, Yu-zhao Wang, Fei-xiang Ding, Mo-Fang Liu, Ming-Hua Lu, Ying Tang, Hong-yu Yu and Shu-han Sun

    Version of Record online : 20 AUG 2009, DOI: 10.1038/emboj.2009.214

  14. Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage

    Molecular Carcinogenesis

    Volume 52, Issue 2, February 2013, Pages: 118–133, Daniel R. Premkumar, Esther P. Jane, Naomi R. Agostino, Joseph D. DiDomenico and Ian F. Pollack

    Version of Record online : 15 NOV 2011, DOI: 10.1002/mc.21835

  15. You have free access to this content
    Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies

    American Journal of Hematology

    Volume 90, Issue 4, April 2015, Pages: E60–E65, Efstathios Kastritis, Maria Roussou, Maria Gavriatopoulou, Magdalini Migkou, Despina Kalapanida, Constantinos Pamboucas, Elisavet Kaldara, Argyrios Ntalianis, Erasmia Psimenou, Savvas T. Toumanidis, Anna Tasidou, Evangelos Terpos and Meletios A. Dimopoulos

    Version of Record online : 9 MAR 2015, DOI: 10.1002/ajh.23936

  16. Addition of bortezomib to standard dose chop chemotherapy improves response and survival in relapsed mantle cell lymphoma

    British Journal of Haematology

    Volume 168, Issue 1, January 2015, Pages: 55–62, Michelle Furtado, Rod Johnson, Anton Kruger, Deborah Turner and Simon Rule

    Version of Record online : 22 AUG 2014, DOI: 10.1111/bjh.13101

  17. You have free access to this content
    Proteasome inhibition aggravates tumor necrosis factor–mediated bone resorption in a mouse model of inflammatory arthritis

    Arthritis & Rheumatism

    Volume 63, Issue 3, March 2011, Pages: 670–680, Karin Polzer, Kirsten Neubert, Silke Meister, Benjamin Frey, Wolfgang Baum, Jörg H. Distler, Eva Gückel, Georg Schett, Reinhard E. Voll and Jochen Zwerina

    Version of Record online : 25 FEB 2011, DOI: 10.1002/art.30177

  18. Functional requirement of dicer1 and miR-17-5p in reactive astrocyte proliferation after spinal cord injury in the mouse

    Glia

    Volume 62, Issue 12, December 2014, Pages: 2044–2060, Peiwei Hong, Mei Jiang and Hedong Li

    Version of Record online : 18 JUL 2014, DOI: 10.1002/glia.22725

  19. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines

    International Journal of Laboratory Hematology

    Volume 34, Issue 3, June 2012, Pages: 237–247, B. ZHENG, R. ZHOU, Y. GONG, X. YANG and Q. SHAN

    Version of Record online : 7 DEC 2011, DOI: 10.1111/j.1751-553X.2011.01384.x

  20. You have full text access to this Open Access content
    Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition

    Cancer Science

    Volume 101, Issue 6, June 2010, Pages: 1403–1408, Daisuke Tamura, Tokuzo Arao, Kaoru Tanaka, Hiroyasu Kaneda, Kazuko Matsumoto, Kanae Kudo, Keiichi Aomatsu, Yoshihiko Fujita, Takashi Watanabe, Nagahiro Saijo, Yoshikazu Kotani, Yoshihiro Nishimura and Kazuto Nishio

    Version of Record online : 15 MAR 2010, DOI: 10.1111/j.1349-7006.2010.01544.x